Apeloa Pharmaceutical Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Apeloa Pharmaceutical Co Ltd with three other
companies in this sector in China:
Shandong Xinhua Pharmaceutical Company Limited
sales of 4.01 billion Chinese Renmimbi [US$583.33 million]
of which 44%
was Chemical Raw Medicine),
China Resources Double-Crane Pharmaceutical Company Limited
(5.49 billion Chinese Renmimbi [US$797.99 million]
of which 62%
was Non- transfusion), and
ChangChun High New Technology Industries
(2.87 billion Chinese Renmimbi [US$417.55 million]
of which 81%
Apeloa Pharmaceutical Co Ltd reported sales of 4.77 billion Chinese Renmimbi (US$693.05 million)
December of 2016.
increase of 10.0%
versus 2015, when the company's sales were 4.34 billion Chinese Renmimbi.
Sales at Apeloa Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 211%).
Sales of Healthcare and Pharmaceutical saw an increase
10.1% in 2016, from
4.32 billion Chinese Renmimbi to 4.76 billion Chinese Renmimbi.
Not all segments of Apeloa Pharmaceutical Co Ltd experienced an increase in sales in 2016:
sales of Other fell 4.3% to 12.59 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).